Background Surgical and clinical management of craniopharyngiomas is associated with
high long-term morbidity especially in the case of hypothalamic involvement. Improvements …

Simple Summary Craniopharyngiomas (CPs) currently represent one of the most
challenging diseases to deal with in the group of skull base tumors. Due to their location …

Purpose Molecular diagnostics including next generation gene sequencing are increasingly
used to determine options for individualized therapies in brain tumor patients. We aimed to …

Craniopharyngioma (CP) is an intracranial benign tumor that behaves aggressively due to
its location, infiltration of the surrounding nervous tissue and high capacity for recurrence …

Background: The proximity of craniopharyngiomas (CPs) to critical neurovascular structures
can lead to a host of neurologic and endocrine complications that lead to difficulty with …

What is known and objective: The BRAF‐V600E genetic mutation offers a potential targeted
therapy for the treatment of papillary craniopharyngiomas. Case summary: A 35‐year‐old …

Objective Papillary craniopharyngioma (PCP) was previously believed to occur only in
adults. Sporadic pediatric PCP (PPCP) confirmed by detection of BRAF V600E mutation has …

Background Craniopharyngioma is a rare intracranial tumor, with a high morbidity rate due
to its common refractiveness to conventional treatments. BRAF V600E mutation has recently …

Craniopharyngiomas are rare intracranial tumors that mainly arise in the sellar/parasellar
(particularly suprasellar) region. They present in both children and adults with a wide range …

颅内肿瘤严重影响了人类的身心健康， 由于肿瘤的性质与生长部位的不同，
因此对颅内肿瘤患者进行个体化、 特异性的治疗已成为当下研究的热点 …